Open Access

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine

  • Wang Junwei1,
  • Zhang Xiumin1,
  • Ye Jing1,
  • Yang Shoujing1 and
  • Li Zengshan1, 2Email author
Cancer Cell International201717:10

https://doi.org/10.1186/s12935-016-0375-5

Received: 22 December 2016

Accepted: 22 December 2016

Published: 6 January 2017

The original article was published in Cancer Cell International 2016 16:45

Erratum to: Cancer Cell Int (2016) 16:45 DOI 10.1186/s12935-016-0317-2

Following publication of the original article [1] it was brought to our attention that the second author name had been misspelt. Please note that the second author name should be “Zhang Xiumin” and not “Zhan Xiumin” as was originally presented.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
The State Key Laborotary of Cancer Biology, Xijing Hospital of the Fourth Military Medical University
(2)
The Pathology Department, Fourth Military Medical University

Reference

  1. Junwei W, Xiumin Z, Shoujing Y, Zengshan L. In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine. Cancer Cell Int. 2016;16:45. doi:10.1186/s12935-016-0317-2.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement